Prediction of risk and overall survival of pancreatic cancer from blood soluble immune checkpoint-related proteins

Prediction of risk and overall survival of pancreatic cancer from blood soluble immune checkpoint-related proteins

BackgroundImmune checkpoint inhibition holds promise as a novel treatment for pancreatic ductal adenocarcinoma (PDAC). The clinical significance of soluble immune checkpoint (ICK) related proteins have not yet fully explored in PDAC.MethodsWe comprehensively profiled 14 soluble ICK-related proteins...

Full description

Bibliographic Details
Main Authors:	Sai Pan, Wenting Zhao, Yizhan Li, Zhijun Ying, Yihong Luo, Qinchuan Wang, Xiawei Li, Wenjie Lu, Xin Dong, Yulian Wu, Xifeng Wu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Series:	Frontiers in Immunology
Subjects:	soluble immune checkpoint-related protein pancreatic cancer immune subtype survival prediction model
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1189161/full

Similar Items

Soluble Immune Checkpoint-Related Proteins in Blood Are Associated With Invasion and Progression in Non-Small Cell Lung Cancer
by: Qinchuan Wang, et al.
Published: (2022-07-01)

Evaluating distinct KRAS subtypes as potential biomarkers for immune checkpoint inhibitor efficacy in lung adenocarcinoma
by: Qi Wang, et al.
Published: (2023-10-01)

Gene set-based identification of two immune subtypes of diffuse large B cell lymphoma for guiding immune checkpoint blocking therapy
by: Zhe Li, et al.
Published: (2022-10-01)

A comprehensive analysis of immune features and construction of an immune gene diagnostic model for sepsis
by: Haiyan Xue, et al.
Published: (2023-12-01)

Editorial: Soluble immune checkpoints: Novel physiological immunomodulators
by: Antonio Riva, et al.
Published: (2023-03-01)

Advances in immunotyping of colorectal cancer
by: Yinhang Wu, et al.
Published: (2023-10-01)

Corrigendum: Immunogenomic landscape in breast cancer reveals immunotherapeutically relevant gene signatures
by: Tao Wang, et al.
Published: (2023-01-01)

Immunogenomic Landscape in Breast Cancer Reveals Immunotherapeutically Relevant Gene Signatures
by: Tao Wang, et al.
Published: (2022-01-01)

Advances in immune checkpoint inhibitors induced-cardiotoxicity
by: Xiang Li, et al.
Published: (2023-02-01)

Soluble Forms of Immune Checkpoints and Their Ligands as Potential Biomarkers in the Diagnosis of Recurrent Pregnancy Loss—A Preliminary Study
by: Michał Zych, et al.
Published: (2023-12-01)

Imaging phenotypes from MRI for the prediction of glioma immune subtypes from RNA sequencing: A multicenter study
by: Jingxian Duan, et al.
Published: (2023-04-01)

Identification of novel immune subtypes and potential hub genes of patients with psoriasis
by: Yingxi Li, et al.
Published: (2023-03-01)

Characterizing Spring Phenological Changes of the Land Surface across the Conterminous United States from 2001 to 2021
by: Wei Wu, et al.
Published: (2023-01-01)

Identification of necroptosis-related subtypes, development of a novel signature, and characterization of immune infiltration in colorectal cancer
by: Mengyu Sun, et al.
Published: (2022-12-01)

Soluble immune checkpoint molecules: mechanism of formation, function, role in malignant neoplasms (Review)
by: Tatyana V. Glazanova, et al.
Published: (2019-08-01)

Unravelling soluble immune checkpoints in chronic lymphocytic leukemia: Physiological immunomodulators or immune dysfunction
by: Alicia Landeira-Viñuela, et al.
Published: (2022-09-01)

AI based failure analysis for one type of cables in power systems
by: Du, Qinchuan
Published: (2023)

Characterization of polyamine metabolism predicts prognosis, immune profile, and therapeutic efficacy in lung adenocarcinoma patients
by: Zhouhua Li, et al.
Published: (2024-04-01)

The Immune Subtypes and Landscape of Advanced-Stage Ovarian Cancer
by: Minjie Zhang, et al.
Published: (2022-09-01)

Dissecting tumor antigens and immune subtypes for mRNA vaccine development in breast cancer
by: Lang Li, et al.
Published: (2023-09-01)

The Role of Soluble LAG3 and Soluble Immune Checkpoints Profile in Advanced Head and Neck Cancer: A Pilot Study
by: Andrea Botticelli, et al.
Published: (2021-07-01)

Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy
by: Chris Y. Chiu, et al.
Published: (2023-03-01)

Identification of tumor antigens and immune subtypes in breast cancer for mRNA vaccine development
by: Ruo Qi Li, et al.
Published: (2022-09-01)

A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors
by: Silvia Mezi, et al.
Published: (2023-07-01)

Immune checkpoints expression patterns in early-stage triple-negative breast cancer predict prognosis and remodel the tumor immune microenvironment
by: Jinguo Zhang, et al.
Published: (2023-02-01)

Bladder Cancer Exhibiting High Immune Infiltration Shows the Lowest Response Rate to Immune Checkpoint Inhibitors
by: Shen Pan, et al.
Published: (2019-10-01)

Identification of Ferroptosis-Related Biomarkers for Diagnosis and Molecular Classification of Staphylococcus aureus-Induced Osteomyelitis
by: Shi X, et al.
Published: (2023-04-01)

Molecular subtypes based on cuproptosis regulators and immune infiltration in kidney renal clear cell carcinoma
by: Aibin Liu, et al.
Published: (2022-10-01)

Identification of a prognostic risk-scoring model and risk signatures based on glycosylation-associated cluster in breast cancer
by: Shengnan Gao, et al.
Published: (2022-10-01)

Exploitation of tumor antigens and construction of immune subtype classifier for mRNA vaccine development in bladder cancer
by: Xin Zhang, et al.
Published: (2022-11-01)

The immune subtypes and landscape of sarcomas
by: Weiwei Weng, et al.
Published: (2022-09-01)

Investigation of two ferroptosis-related molecular subtypes and biomarkers in the progression of gastric adenocarcinoma
by: Weiqun Lu, et al.
Published: (2022-12-01)

Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients
by: Ilaria Grazia Zizzari, et al.
Published: (2020-11-01)

Molecular Evolutionary Landscape of the Immune Microenvironment of Head and Neck Cancer
by: Baoyi Shao, et al.
Published: (2023-07-01)

The regulation of immune checkpoints by the hypoxic tumor microenvironment
by: Min Hu, et al.
Published: (2021-05-01)

6-Year trajectory of fasting plasma glucose (FPG) and mortality risk among individuals with normal FPG at baseline: a prospective cohort study
by: Wanlu Li, et al.
Published: (2023-08-01)

Integrated clinical analysis and data mining assessed the impact of NOX4 on the immune microenvironment and prognosis of pancreatic cancer
by: Xin Zhao, et al.
Published: (2023-02-01)

Corrigendum: Construction of an immune-related signature for predicting the ischemic events in patients undergoing carotid endarterectomy
by: Shifu Li, et al.
Published: (2023-01-01)

Construction of an immune-related signature for predicting the ischemic events in patients undergoing carotid endarterectomy
by: Shifu Li, et al.
Published: (2022-10-01)

Identification of immune microenvironment subtypes and signature genes for Alzheimer’s disease diagnosis and risk prediction based on explainable machine learning
by: Yongxing Lai, et al.
Published: (2022-12-01)